# ## ## |for the year ended
Contents|31 March 2021|| |---|---|---| |Trustee's
Report||3| |Statement ofTrustee's|responsibilities.|.13| |Independent
Auditor's|Report.|.14| |Statement of Financial|Activities.|.1S| |Balance Sheet.||.19| |Statement ofCash Flows||20| |Notes to the accounts||21| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |||||||2021|||2020|| |---|---|---|---|---|---|---|---|---|---|---| ||||||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total| ||||Note||Funds|Funds||Funds|Funds|| ||||||g000|K'000|8000|K'000|E'000|6000| |income from:||||||||||| |Donations|||||312|97|409|482||| |Legacies|||||335|263|598|9||| |Grants||||||178|178|||| ||||||647|538|1,185|491|2|493'| |Investments|||||26|6|32|48|6|54| |Tots I income|||||673|544|1,217|539|8|547| |Expenditure
on:||||||||||| |Raising funds:||||||||||| |Other trading costs|||||(3)||(3)|(44)||(44)| |Investrpent
management||costs||||||(5)|(1)|(8)| |Charitable
activities||||4|(1,639)|(514)|(2,153)|(975)|(27)|(1,002)| |Total expenditure|||||(1,642)|(514)|(2,156)|(1,024)|(28)|(1,052)| |Gains on investments|||||||724|(18)|21|| |Net movement|in funds||||(311)|96|(215)|(503)|1|(502)| |Fund balances|brought forward||||3,571|546|4,117|4,074|545|4,619| |Fund balances carried||forward|||3,260|642|3,902|3,571|546|4,117| ## ## |Balance She|et as at 31 March 202|1||||| |---|---|---|---|---|---|---| |||Note|2021||2020|| ||||R'000|f'000|f'000|6000| |Fixed Assets||||||| |Investments|||3,497||3,440|| |||||3,497||3,440| |Current Assets||||||| |Debtors|||323||9|| |Cash at Bank and in|Hand||768||1,445|| ||||1,091||1,454|| |Creditors: Amounts|Falling Due Within One Year||(686)||P?7)|| |Net Current Assets||||405||677| |Total Assets Less Current Liabilities||||3,902||4,11?| |Tota I Net Assets||||3,902||4,117| |Funds ofthe Charity||||||| |Restricted
Income Funds||10||642||546| |Designated
Income Funds||10||3,174||3,529| |General
income Funds||10||86||42| |Total Charity Funds||||3,902||4,117| ## ## ||||||2021|2020| |---|---|---|---|---|---|---| |||||Notes|f.'000|F000| |Cash inflow from operating
activities:||||||| |Net cash|provided
by (used in) operating|activities||A|(1,376)|(70)| |Cash inflow from investing
activities:||||||| |Dividends|and interest
from investments||||32|54| |Proceeds|from the disposal of investments||||751|793| |Purchase|ofinvestments||||(84)|(87)| |Net cash|provided
by (used in) investing||activities||699|760| |Change|in cash and cash equivalents|in|the year||(677)|690| |Cash and cash equivalents
at 1 April 2020|||||1,445|755| |Cash and cash equivalents
at 31 March|||2021||768|1,445| |A|Reconciliation
ofnet movement|in funds|in funds|to net cash flow from|operating|activities|| |---|---|---|---|---|---|---|---| |||||||2021|2020| |||||||8'000|F'000| ||Net movement
in funds {asper the|statement||offinancial activities)||(215)|(502)| ||Adjustments
for:||||||| ||(Gains) losses on investments|||||(724)|(3)| ||Dividends
and interest from investments|||||(32)|(54)| ||(Increase) decrease
in debtors|||||(314)|306| ||Increase (decrease)
in creditors|||||(91)|183| ||Net cash provided
by.(used in) operating||activities||{1,376)||{70)| |B|Analysis of cash and cash equivalents||||||| |||||||2020|2020| |||||||E'000|R'000| ||Cash at bank and in hand|||||268|1,445| ||Cash held by investment
managers|||||500|| ||Total cash and cash equivalents|||||768|1,446| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |2. Analysis ofDon|ations, Legacies a|nd Grants||||| |---|---|---|---|---|---|---| |||2021|||2020|| ||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total| ||Funds|Funds||Funds|Funds|| ||R'000|K'000|R'000|K'000|K'000|8000| |Donations|312|97|409|482|2|484| |Legacies|335|263|598|9||9| |Grants receivable||178|178|||| ||647|538|1,185|491|2|493| |||2021|||2020|| |---|---|---|---|---|---|---| ||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total| ||Funds|Funds||Funds|Funds|| ||F'000|F'000|R'000|K'000|K'000|E'000| |NHSCT|stage 1 grant 1stpayment|32|32|||| |NHSCT|stage 1 grant 2nd payment|46|46|||| |NHSCT|BAME grant|50|50|||| |NHSCT|second wave funding|50|50|||| |||178|178|||| ## |3. Allocatio|n ofSupport Costs and Overheads|||| |---|---|---|---|---| |||2021|'|2020| |||Total||Total| |||8000||R'000| |Accountancy|support|49||48| |External audit||9||12| |Bank charges||1||2| |Software maintenance||3||4| |||62||66| ## |The table||below shows the categories of programmes|below shows the categories of programmes|below shows the categories of programmes|that the Charity has supported|that the Charity has supported|that the Charity has supported|during|| |---|---|---|---|---|---|---|---|---|---| |the financial year under review.|||||||||| |||||2021||||2020|| ||||Unrestricted|Restricted|Total|Unrestricted|Restricted||Total| ||||Funds|Funds||Funds|Funds||| ||||f'000|R'000|E'000|f,'000||2000|K'000| |'Patients'|welfare and amenities||39|52|91|205|||205| |Staff welfare and education|||54|170|224|113|||118| |Purchase||ofclinical equipment|458||458|148||15|163| |Enhancing||patient environment|998|281|1,279|409|||409| |Patient education||||||1|||1| |Research|||39||39|40|||40| |Support costs|||51||62|59|||66| ||||1,639|514|2,153|975||27|1,002| ## ## ## |||||31 March|31 March| |---|---|---|---|---|---| |||||2021|2020| |||||6'000|K'000| |Listed Investments|||||| |Market value at 1 April||||3,440|4,143| |Additions
to investments|at cost|||84|87| |Disposals at book value||||(751)|(720)| |Net Unrealised
investment||gains/(losses)||724|(7o)| |Market value at 31 March||||3,497|3,440| |Cash held by investment||managers|for re-investment||| |Carrying
value at 31 March||||3;497|3,440| |Historic cost of investments||at 31 March||2,854|2,727| |nvestments
held at 31|INarch comprise|d the following:|| |---|---|---|---| |||31 March|31March| |||2021|2020| |||K'000|K'000| |UK common investment|funds|1,042|825| |Overseas hedge funds||2,455|2,615| |||3,497|3,440| ## |7. Total|Gr|oss Incom|e from I|nvestments||| |---|---|---|---|---|---|---| |||||Unrestricted|Restricted|2021| |||||Funds|Funds|Total| |||||K'000|f.'000|f,'000| |Return on|investments||held:|||| |UK common||investment|funds|25||31| |Overseas|hedge funds|||||| |Bank interest||||||| |||||26||32| |||||Unrestricted|Restricted|2020| |||||Funds|Funds|Total| |||||6'000|K'000|Z'000| |Return on|investments||held:|||| |UK common||investment|funds|27|4|31| |Overseas|hedge funds|||14|2|16| |Bank interest||||?||7| |||||48||| ## ## |Debtors|||| |---|---|---|---| |||31Ilarch|31 March| |||2021|2020| |||F'000|f'000| |Amounts
falling due within one year:|||| |Prepayments|and accrued income|314|| |Other debtors||9|| |Total debtors||323|| ## |Cash|at|Bank|and in Han|d||| |---|---|---|---|---|---|---| ||||||31|31| ||||||INarch|INarch| ||||||2021|2020| ||||||6000|K'000| |Cash|at|bank|and in hand||766|1,445| |Cash|in|hand|represented|petty cash ofF200 (2020 -8200).||| ## ## |Creditors|||| |---|---|---|---| |||31 March|31March| |||2021|2020| |||8000|f'000| |Amounts|falling due within one year:||| |Amounts|due to related parties|191|3| |Other creditors||3|2| |Grants payable||483|760| |Accruals||9|12| |||686|777| ## ## ## ||||||||Balance at||||Balance at| |---|---|---|---|---|---|---|---|---|---|---|---| ||||||||1 April|||Gains and|31INarch| ||||||||2020|Income|Expenditure|Losses|2021| ||||||||E'000|E'000|F000|f'000|R'000| |Restricted|||||||||||| |Stroke Services Development||||Charitable|Fund RHCH||24|267|(67)|9|233| |Winchester
Hospice Fund|||||||263|2|(283)|18|| |RHCH Staff Benefit|||||||178|7|(3)|18|200| |Arthritis
Research - Legacy|||I H Spain||||81|1|(2)|8|88| |Covid-19||||||||217|(150)|10|77| |BAME StaffSupport||||||||50|(9)|3|| |RHCH Patient Benefit|||||||||||| |Total restricted funds|||||||||(514)||| |Unrestricted|||||||||||| |Designated
funds|||||||||||| |Magic Wand Appeal|||||||52||(12)|5|46| |Orthopaedic
Department||General Purposes|||||480||14|46|544| |RHCH Chapel|||||||125||(6)|11|132| |Pseudomyxoma/Colorectal|||Research||||173|47|(31)|16|205| |Clinical Haematology|||||||71||(51)|6|2?| |Liver Fund|||||||157||(14)|16|163| |Oncology
Unit (Previously||EH||Unit orWessex)|||146|84|(25)|17|222| |Ward C2|||||||51||(1)|. 6|60| |Cardiology
Education|Fund||||||99||(4)|10|106| |Paediatric Wards
NHH|||||||77||(37)|8|51| |Coronary
Care Unit|||||||71||(5)|7|75| |Winchester
Medical Foundation||||Charitable||Fund|317||(275)|22|64| |Winchester Hospice Fund|||||||77?|152|(902)|31|58| |Other designated|||||||933|125|(83)|446|1,421| |Total designated
funds|||||||3,529|430|(1,432)||3,174| |General Funds|||||||42|243|(210)||86| |Total unrestricted
funds|||||||3,571|673|(1,642)||3,260| |Total Funds|||||||4,117|1,217|(2,156)|724|3,902| ## ## ||||||||Balance at||||Balance at| |---|---|---|---|---|---|---|---|---|---|---|---| ||||||||1 April|||Gains and|31 Nlarch| ||||||||2019|Income|Expenditure|Losses|2020| ||||||||f 000|F000|6000|F000|R'000| |Restricted|||||||||||| |Stroke Services Development||||Charitable|Fund RHCH||31||(9)||24| |Winchester
Hospice|Fund||||||250||(4)|14|263| |RHCH Staff Benefit|||||||177||(6)||178| |Arthritis
Research -|Legacy|||I H Spain|||79||(1)||81| |RHCH Patient Benefit|||||||8||(8)||| |Total restricted funds|||||||||(28)|21|| |Unrestricted|||||||||||| |Designated
funds|||||||||||| |Magic Wand Appeal|||||||71||(23)||52| |Orthopaedic
Department|||General Purposes||||524||(64)|13|480| |RHCH Chapel|||||||136|3|(16)|2|125| |Pseudomyxoma/Coiorectal||||Research|||156|25|{12)|4|173| |Clinical Haematology|||||||87|21|(39)|2|71| |Liver Fund|||||||178|21|(47)|5|157| |Oncology
Unit (Previously|||EH Unit or Wessex)||||133|17|(9)|5|146| |Ward C2|||||||31|22|(3)|1|51| |Cardiology
Education||Fund|||||130|2|{36)|3|99| |Paediatric Wards
NHH|||||||91|8|(24)|2|77| |Coronary
Care Unit|||||||75|3|{9)|2|71| |Winchester
Medical|Foundation
Charitable|||||Fund|654|21|(375)|17|317| |Winchester Hospice|Fund||||||615|196|(54)|20|777| |Other designated|||||||1,131|175|(276)|(97)|933| |Total designated
funds|||||||4,012|523|(987)|(19)|3,529| |General Funds|||||||62|16|{37)||42| |Total unrestricted|funds||||||4,074|539|(1,024)|(18)|3,571| |Total Funds|||||||4,619|547|(1,052)||4,117| ## ## ## ## ## ## ## |Fund balan|ces as at 31 INarch 20|21 are rep|resented
|by:|||| |---|---|---|---|---|---|---|---| |||General|Restricted|2021|General|Restricted|2020| |||Funds|Funds|Total|Funds|Funds|Total| |||f.'000|f'000|f'000|f'000|f'000|R'000| |Investments||3,337|160|3,497|3,073|367|3,440| |Current Assets||350|741|1,091|1,242|212|1,454| |Creditors: Amounts|falling due within one year|(427)|(259)|(686|(744)|(33)|(777)| |||3,260|642|3,902|3,571|546|4,117| ## ## ##